WHITEHAWK THERAPEUTICS, INC. Interest Expense Nonoperating
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Interest Expense Nonoperating of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-12
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for fiscal 2024 was $154.00K, a 33.33% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. interest expense nonoperating for fiscal 2023 was $231.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $38.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $38.00K derived: sum of 3 quarters · filed 2026-03-12 | $96.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $38.00K derived: sum of 2 quarters · filed 2026-03-12 | $96.00K derived: sum of 3 quarters · filed 2026-03-12 | $154.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $38.00K 10-Q · filed 2025-11-06 | $96.00K derived: sum of 2 quarters · filed 2025-11-06 | $154.00K 10-Q · filed 2025-11-06 | $211.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $58.00K 10-Q · filed 2025-08-07 | $116.00K 10-Q · filed 2025-08-07 | $173.00K derived: sum of 3 quarters · filed 2025-08-07 | $231.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $58.00K 10-Q · filed 2025-05-08 | $115.00K derived: sum of 2 quarters · filed 2025-05-08 | $173.00K derived: sum of 3 quarters · filed 2025-05-08 | $231.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $115.00K derived: sum of 2 quarters · filed 2025-03-28 | $173.00K derived: sum of 3 quarters · filed 2025-03-28 | $231.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $58.00K 10-Q · filed 2024-11-06 | $116.00K derived: sum of 2 quarters · filed 2024-11-06 | $174.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $58.00K 10-Q · filed 2024-08-07 | $116.00K 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |